, /PRNewswire/ –HealthTree Foundation was included in a group of 20 out of 700 applications for…
Category: Insights
Microsofts Fourth Failed Invalidation Attempt Brings Newman Infinite Touch Patent Dispute to China Supreme Peoples Court
Backed by four failed challenges and CNIPA’s recent Public Lecture presentation of its “Top 10 Case”…
FDA approves CAPLYTA® (lumateperone) sNDA with robust new data supporting reduced risk of relapse in schizophrenia
CAPLYTA® reduced relapse risk by 63 percent, with 84 percent of patients with schizophrenia relapse-free over…
MAHA Action Opposes Farm Bill Sections That Would Shield Chinese State-Owned Syngenta From U.S. Failure-to-Warn Lawsuits
Sections 10205, 10206, and 10207 of H.R. 7567 would block American families from holding pesticide manufacturers…
Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.
, /PRNewswire/ — Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, today announced an agreement…
Galaxy Therapeutics Submits Final Module of PMA to U.S. FDA for SEAL™ Device in Wide-Neck Bifurcation Aneurysms
, /PRNewswire/ –Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms,…
"Timbit" Carbon Taxes and Net Zero Goals Limit Canadian Economy says Friends of Science Society
, /PRNewswire/ — The Canadian Climate Institute claims that the industrial carbon price amounts to only…
Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional…
Graphite One Provides FAST-41 Permitting Update For Graphite Creek Project
Company Remains on Track with Targeted Federal Permitting Decision by September 2026 Highlights Strategic Importance of…
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia
Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs…